Company intelligence / Profile preview
Institute of Vaccines and Medical Biologicals
- Ownership
- Private
- Development stage
- Commercial
Overview
IVAC has a long track record of supplying hundreds of millions of vaccine doses for Vietnam’s National Expanded Programme on Immunization. Its products have contributed to the elimination of neonatal tetanus in Vietnam by 2005 and significant reductions in infectious disease morbidity/mortality. The institute also produces various sera for prophylactic use against rabies and snakebites as well as interferon-based therapies[4].
- Therapeutic areas
- OtherOncologyInfectious Diseases
- Modalities
- VaccineBiologicRecombinant protein
- Industry
- Biotech
Drug pipeline
5 assets4 more assets in the full pipeline.
Request access →Partnerships
Beyond the preview
Go deeper on Institute of Vaccines and Medical Biologicals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Institute of Vaccines and Medical Biologicals.